Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing CE Provider #: 50-290
Nurses will receive 1.00 contact hours for participating in this course.
Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing CE Provider #: 50-290
Nurses will receive 1.00 contact hours for participating in this course.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]
Florida Board of Medicine CE Provider #: 50-290
Outline:
Section 1: Introduction
A. About This Course
B. Learning Objectives
Section 2: Pharmacological Concepts
A. Art and Science of Pharmacology
B. Pharmacokinetics
C. Pharmacodynamics
D. Intrinsic Activity of Drug-Receptors
E. Agonists
F. Antagonists
Section 3: The Nervous System
A. Efferent Nervous System
B. Autonomic Nervous System
C. Sympathetic Nervous System
D. Parasympathetic Nervous System
E. Chemical Signaling Between Cells
F. Types of Neurotransmitters
Section 4: Autonomic Agents: Adrenergic
A. The Adrenergic Receptors
B. Adrenergic Agonists
C. Adrenergic Antagonists
Section 5: Autonomic Agents: Cholinergic
A. Cholinergic Receptors
C. Cholinergic Agonists
D. Cholinergic Antagonists
Section 6: Antiarrhythmics
A. Introduction to Antiarrhythmics
B. Cardiac Electrophysiology
C. Causes of Arrhythmias
D. Class I: Sodium Channel Blockers
E. Class II: Beta Blockers
F. Class III: Potassium Channel Blockers
G. Class IV: Calcium Channel Blockers
H. Others: Digoxin, Adenosine, and Magnesium
Section 7: Conclusion
A. Course Contributors
B. Resources
C. References
Kristen Ponichtera BSN, RN, CFRN, CTRN, CCRN brings 10 years of clinical and educational experience in the fields of critical care, emergency and aviation medicine. Serving as Program Director of Flight & Critical Care Nursing Education, she has created original comprehensive educational courses as well as has contributed to best-selling publications. An active member of the Air & Surface Transport Nurses Association (ASTNA), the American Association of Critical Care Nurses (AACN), and the Society of Trauma Nurses (STN), she has been revered as a resource and mentor to many clinicians serving in these specialties. Fulfilling roles as a registered nurse, ECMO specialist, director and clinical educator, Kristen brings a unique and original perspective to the realm of medical education. Disclosure: Kristen Ponichtera BSN, RN, CFRN, CTRN, CCRN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Expert Reviewer: David Hoeft, MD
David Hoeft, MD is a board certified Anesthesiologist at American Anesthesiology of New York. In addition to his strong background in physical and chemical sciences, David is actively involved in graduate medical education and research, and brings clinical and didactic expertise across the continuum of medical practice. Disclosure: David Hoeft, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.